CVRx (CVRX) Cash from Financing Activities (2020 - 2026)
CVRx (CVRX) posted quarterly Cash from Financing Activities of $8.9 million for Q1 2026, down 7.62% year-over-year from $9.6 million in Q1 2025, and up 2066.34% quarter-over-quarter from $410000.0 in Q4 2025.
CVRx (CVRX) Cash from Financing Activities (2020 - 2026) Analysis & Trends
CVRx's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $8.9 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 7.62% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $9.8 million (down 84.74% YoY), while the FY2025 annual figure was $10.5 million, down 81.17% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $8.9 million, up from $410000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $40.2 million in Q3 2024, with the low at $7000.0 in Q3 2022.
- The 5-year median for Cash from Financing Activities is $473000.0 (2023), against an average of $6.3 million.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities slumped 99.99% in 2022, then jumped 15666.67% in 2023.
- CVRx's Cash from Financing Activities stood at $7.1 million in 2022, then surged by 118.91% to $15.6 million in 2023, then fell by 11.21% to $13.8 million in 2024, then sank by 97.04% to $410000.0 in 2025, then jumped by 2066.34% to $8.9 million in 2026.
- Business Quant data shows CVRX's Cash from Financing Activities at $8.9 million in Q1 2026, $410000.0 in Q4 2025, and $103000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | CVRx | 76.63 Mn | 12.04 Mn | 13.72 Mn | 1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Mn |
| Jun 30, 2026 | 1.22 Mn |
| Mar 31, 2026 | 8.88 Mn |
| Mar 31, 2026 | 8.88 Mn |
| Dec 31, 2025 | 410,000.00 |
| Dec 31, 2025 | 410,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 392,000.00 |
| Jun 30, 2025 | 392,000.00 |
| Mar 31, 2025 | 9.62 Mn |
| Mar 31, 2025 | 9.62 Mn |
| Dec 31, 2024 | 13.83 Mn |
| Dec 31, 2024 | 13.83 Mn |
| Sep 30, 2024 | 40.20 Mn |
| Sep 30, 2024 | 40.20 Mn |
| Jun 30, 2024 | 472,000.00 |
| Jun 30, 2024 | 472,000.00 |
| Mar 31, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.36 Mn |